$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
Stormy 2026? 3 Defensive Stocks to Weather a Recession
11:06am, Tuesday, 23'rd Dec 2025
TPB, JNJ and NEE highlight how defensive stocks can offer stability and steady growth potential amid rising uncertainty for 2026.
5 Big Drug Stocks That May Continue to Outperform in 2026
09:51am, Tuesday, 23'rd Dec 2025
Five big drugmakers, including LLY and JNJ, are riding innovation, dealmaking and pipeline momentum that could help them keep outperforming in 2026.
The Dividend King Buy-and-Hold Strategy That Can Surge 100% in 10 Years
07:45am, Tuesday, 23'rd Dec 2025
Coca-Cola has increased its dividend for 63 straight years. Johnson & Johnson has matched Coca-Cola's dividend growth streak.
Clarius Group LLC Has $3.42 Million Stock Holdings in Johnson & Johnson $JNJ
05:20am, Tuesday, 23'rd Dec 2025
Clarius Group LLC decreased its position in Johnson and Johnson (NYSE: JNJ) by 25.9% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commiss
J&J Wins FDA Nod for Subcutaneous Version of NSCLC Drug Rybrevant (Revised)
04:56am, Tuesday, 23'rd Dec 2025
JNJ wins FDA approval for a subcutaneous version of Rybrevant, cutting treatment time to minutes and boosting convenience across NSCLC indications.
Johnson & Johnson Hit With Record $1.5 Billion US Verdict Over Talc Cancer Claim
02:50am, Tuesday, 23'rd Dec 2025
Baltimore jury awards $1.5 billion against Johnson and Johnson in record talc-asbestos mesothelioma verdict; company plans to appeal.
J&J vows appeal after US jury hits it with record $1.5 billion talc cancer award
12:34am, Tuesday, 23'rd Dec 2025
A Baltimore jury ordered Johnson & Johnson and its subsidiaries to pay over $1.5 billion to a woman who claimed decades of exposure to asbestos in the company's talc-based products caused her peritone
Over $1.5 Billion Baltimore Verdict Holds Johnson & Johnson Liable Over Iconic Baby Powder
11:15pm, Monday, 22'nd Dec 2025
BALTIMORE--(BUSINESS WIRE)--A Baltimore city jury has returned a verdict in favor of Cherie A. Craft, awarding her over $1.5 billion after finding that Johnson & Johnson and its subsidiaries exposed h
J&J Stock Trading Above 50- & 200-Day SMA for 6 Months: How to Play
12:26pm, Monday, 22'nd Dec 2025
J&J has been trading above its 50- and 200-day SMAs for six months as strong 2025 execution, new drugs and pipeline progress support bullish momentum.
Perpetual Ltd Sells 4,180 Shares of Johnson & Johnson $JNJ
07:18am, Monday, 22'nd Dec 2025
Perpetual Ltd trimmed its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 10.8% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). Th
Rydar Equities Inc. Sells 3,178 Shares of Johnson & Johnson $JNJ
06:36am, Monday, 22'nd Dec 2025
Rydar Equities Inc. cut its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 55.8% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commis
Johnson & Johnson $JNJ Shares Purchased by Foster Victor Wealth Advisors LLC
05:56am, Monday, 22'nd Dec 2025
Foster Victor Wealth Advisors LLC boosted its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 3.4% during the third quarter, according to the company in its most recent filing with the Securi
Johnson & Johnson $JNJ Shares Acquired by Fairvoy Private Wealth LLC
05:24am, Monday, 22'nd Dec 2025
Fairvoy Private Wealth LLC boosted its position in Johnson and Johnson (NYSE: JNJ) by 245.5% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission.
Cyndeo Wealth Partners LLC Increases Stock Position in Johnson & Johnson $JNJ
05:24am, Monday, 22'nd Dec 2025
Cyndeo Wealth Partners LLC raised its stake in Johnson and Johnson (NYSE: JNJ) by 63.3% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commissi
Bartlett & CO. Wealth Management LLC Has $47.19 Million Stake in Johnson & Johnson $JNJ
03:26am, Monday, 22'nd Dec 2025
Bartlett and CO. Wealth Management LLC lessened its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 5.1% during the undefined quarter, according to its most recent filing with the Securities
Sign In
Buy JNJ